Metagenomi
0
Funds holding %
of 6,759 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
45% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 11
10% more funds holding
Funds holding: 48 [Q1] → 53 (+5) [Q2]
0% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 14
2.64% less ownership
Funds ownership: 33.75% [Q1] → 31.1% (-2.64%) [Q2]
64% less capital invested
Capital invested by funds: $133M [Q1] → $47.4M (-$85.8M) [Q2]
100% less funds holding in top 10
Funds holding in top 10: 1 [Q1] → 0 (-1) [Q2]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$7
240%
upside
Avg. target
$11.33
450%
upside
High target
$17
725%
upside
6 analyst ratings
6 positive
100%
0 neutral
0%
0 negative
0%
HC Wainwright & Co. Mitchell Kapoor 30% 1-year accuracy 12 / 40 met price target | 240%upside $7 | Buy Reiterated | 15 Oct 2024 |
HC Wainwright & Co. Mitchell Kapoor 30% 1-year accuracy 12 / 40 met price target | 240%upside $7 | Buy Reiterated | 6 Sept 2024 |
Chardan Capital Geulah Livshits 30% 1-year accuracy 8 / 27 met price target | 628%upside $15 | Buy Maintained | 5 Sept 2024 |
HC Wainwright & Co. Mitchell Kapoor 30% 1-year accuracy 12 / 40 met price target | 240%upside $7 | Buy Maintained | 21 Aug 2024 |
Chardan Capital Geulah Livshits 30% 1-year accuracy 8 / 27 met price target | 628%upside $15 | Buy Maintained | 19 Aug 2024 |
Financial journalist opinion
Based on 265 articles about MGX published over the past 30 days
Charts implemented using Lightweight Charts™